Gambro expands product recall after more patients die following dialysis treatment
This article was originally published in Clinica
Executive Summary
Gambro Healthcare has expanded its recall of blood tubing sets outside the US following the deaths of a further two patients after dialysis treatment. This brings the total number of deaths to four. The company organised the US recall of three lots of COBE Centrysystem 3 blood tubing last month after two patients died and around 30 patients became ill after treatment in clinics in Maryland, Nebraska and Massachusetts (see Clinica No 810, p 10).